Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Inhibitory effect of imipramine on the human corticotropin-releasing-hormone gene promoter activity operates through a PI3-K/AKT mediated pathway.

Basta-Kaim A, Budziszewska B, Jaworska-Feil L, Tetich M, Kubera M, Leśkiewicz M, Lasoń W.

Neuropharmacology. 2005 Aug;49(2):156-64. Epub 2005 Apr 1.

PMID:
15996564
2.

Antipsychotic drugs inhibit the human corticotropin-releasing-hormone gene promoter activity in neuro-2A cells-an involvement of protein kinases.

Basta-Kaim A, Budziszewska B, Jaworska-Feil L, Tetich M, Kubera M, Leśkiewicz M, Otczyk M, Lasoń W.

Neuropsychopharmacology. 2006 Apr;31(4):853-65.

3.

Effects of neurosteroids on the human corticotropin-releasing hormone gene.

Budziszewska B, Zając A, Basta-Kaim A, Leśkiewicz M, Steczkowska M, Lasoń W, Kaciński M.

Pharmacol Rep. 2010 Nov-Dec;62(6):1030-40.

4.

Regulation of the human corticotropin-releasing-hormone gene promoter activity by antidepressant drugs in Neuro-2A and AtT-20 cells.

Budziszewska B, Jaworska-Feil L, Tetich M, Basta-Kaim A, Kubera M, Leśkiewicz M, Lasoń W.

Neuropsychopharmacology. 2004 Apr;29(4):785-94.

5.

Effect of antidepressant drugs on the human corticotropin-releasing-hormone gene promoter activity in neuro-2A cells.

Budziszewska B, Jaworska-Feil L, Tetich M, Basta-Kaim A, Kubera M, Leśkiewicz M, Lasoń W.

Pol J Pharmacol. 2002 Nov-Dec;54(6):711-6.

6.

Calcium/calmodulin kinase IV pathway is involved in the transcriptional regulation of the corticotropin-releasing hormone gene promoter in neuronal cells.

Yamamori E, Asai M, Yoshida M, Takano K, Itoi K, Oiso Y, Iwasaki Y.

J Mol Endocrinol. 2004 Dec;33(3):639-49.

PMID:
15591024
8.

OxLDL induces mitogen-activated protein kinase activation mediated via PI3-kinase/Akt in vascular smooth muscle cells.

Chien MW, Chien CS, Hsiao LD, Lin CH, Yang CM.

J Lipid Res. 2003 Sep;44(9):1667-75. Epub 2003 Jun 16.

9.

EGF stimulates mesangial cell mitogenesis via PI3-kinase-mediated MAPK-dependent and AKT kinase-independent manner: involvement of c-fos and p27Kip1.

Mahimainathan L, Ghosh-Choudhury N, Venkatesan BA, Danda RS, Choudhury GG.

Am J Physiol Renal Physiol. 2005 Jul;289(1):F72-82. Epub 2005 Feb 8.

10.

The involvement of phosphatidylinositol 3-kinase in gonadotropin-releasing hormone-induced gonadotropin alpha- and FSHbeta-subunit genes expression in clonal gonadotroph LbetaT2 cells.

Mutiara S, Kanasaki H, Harada T, Oride A, Miyazaki K.

Mol Cell Endocrinol. 2008 Feb 13;283(1-2):1-11. doi: 10.1016/j.mce.2007.12.001. Epub 2007 Dec 8.

PMID:
18206295
11.

HGF protects corneal epithelial cells from apoptosis by the PI-3K/Akt-1/Bad- but not the ERK1/2-mediated signaling pathway.

Kakazu A, Chandrasekher G, Bazan HE.

Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3485-92.

PMID:
15452053
12.
13.
14.

Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen.

Haynes MP, Li L, Sinha D, Russell KS, Hisamoto K, Baron R, Collinge M, Sessa WC, Bender JR.

J Biol Chem. 2003 Jan 24;278(4):2118-23. Epub 2002 Nov 12.

15.

Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells.

Yang CM, Lin MI, Hsieh HL, Sun CC, Ma YH, Hsiao LD.

J Cell Physiol. 2005 Jun;203(3):538-46.

PMID:
15573401
16.
18.

High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases.

Mineo C, Yuhanna IS, Quon MJ, Shaul PW.

J Biol Chem. 2003 Mar 14;278(11):9142-9. Epub 2003 Jan 2.

19.

Effects of neurosteroids on glucocorticoid receptor-mediated gene transcription in LMCAT cells--a possible interaction with psychotropic drugs.

Basta-Kaim A, Budziszewska B, Jaworska-Feil L, Leśkiewicz M, Tetich M, Otczyk M, Kubera M, Lasoń W.

Eur Neuropsychopharmacol. 2007 Jan;17(1):37-45. Epub 2006 Mar 6.

PMID:
16581232

Supplemental Content

Support Center